PHARMA INFLUENCERS | NEWSLETTERS | WEBINARS

RESEARCH AND DEVELOPMENT


Newsletter

RESEARCH AND DEVELOPMENT from The Pharmaceutical Marketing Group is a regular email newsletter with news about research and development from the pharmaceutical industry

Direct to your inbox

Stay up to date with the latest appointments by subscribing to RESEARCH AND DEVELOPMENT! from The Pharmaceutical Marketing Group

View the newsletter archive

Research and Development

Updated CheckMate -025 Results Show 26% of Patients Treated with Opdivo are Alive at Five Years in Patients with Previously Treated Advanced or Metastatic...

Admin -
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced...
Read more
Research and Development

Riptide Bioscience Announces Discovery of Novel Immune Checkpoint

Admin -
SAN FRANCISCO--(BUSINESS WIRE)--Riptide Bioscience, Inc., announces the publication in...
Read more
Research and Development

Enrollment Begins for Latiglutenase (IMGX003) Phase 2b Trial for Treatment of Celiac Disease

Admin -
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ImmunogenX is pleased to announce that...
Read more
Research and Development

Investigational Subcutaneous Formulation of Vedolizumab Achieves Clinical Remission at Week 52 in Patients with Moderately to Severely Active Crohn’s Disease

Admin -
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today...
Read more
Research and Development

New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn’s Disease Achieved Clinical Remission After Two...

Admin -
VIENNA--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson...
Read more
Research and Development

Multinational Inflammatory Bowel Disease Survey Uncovers Striking Differences in Patients’ and Physicians’ Treatment Goals and Disease Management Expectations

Admin -
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced the...
Read more
Research and Development

GeneCentric Therapeutics to Present New Analyses of Molecular Characterization and Prediction of Treatment Response in Patients with Muscle Invasive Bladder Cancer (MIBC)

Admin -
DURHAM, N.C.--(BUSINESS WIRE)--GeneCentric Therapeutics today announced it will present...
Read more
Research and Development

U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol-Myers Squibb’s Biologics License Application (BLA) for Lisocabtagene Maraleucel (liso-cel) for Adult Patients with...

Admin -
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced...
Read more
Research and Development

TriSalus Life Sciences and Roger Williams Medical Center Announce Initiation of Phase 1 Clinical Trial for a Novel Delivery Technology That Can Enhance Drug...

Admin -
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences, a company committed to developing...
Read more
Research and Development

AVEO Oncology Announces Publication of Phase 1b/2 Study of Tivozanib in Advanced, Inoperable Liver Cancer in the British Journal of Cancer

Admin -
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced the...
Read more
Research and Development

CARMELINA® subgroup analysis supports long-term cardiovascular and renal safety of linagliptin in older people with type 2 diabetes

Admin -
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim have announced the results of...
Read more
Research and Development

Merck’s KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (mTNBC)

Admin -
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside...
Read more

Receive our newsletters

Get In Touch

All Rights Reserved

The Pharmaceutical Marketing Group